Small cell lung cancer (SCLC) accounts for 15% of all lung cancers and remains an aggressive disease with median survival…
Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase 1/2 RAINFOL™-01 trial showed rinatabart sesutecan (Rina-S®) 100…
Akums Drugs and Pharmaceuticals Ltd., India’s largest contract development and manufacturing organization (CDMO), has announced its consolidated financial results for…
In a country where cardiac care costs continue to burden millions, Medkart introduces a game-changing innovation: India’s first room-temperature stable…
NEW DELHI, Oct. 17, 2025 /PRNewswire/ -- Marengo Asia Hospitals has further strengthened its Western India footprint with majority acquisition of…
BOSTON and ROLLE, Switzerland, Oct. 16, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced…
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving UME and may offer a potential new treatment…
October 17, 2025 16:05 ET | Source: Jade Biosciences Presentations to highlight JADE101’s preclinical safety profile and translational framework guiding…
Across India, women have long been the backbone of community health — managing medicine, caregiving, and decision-making in families. Yet…
Chandigarh University, Uttar Pradesh, continues to break new ground in AI-augmented multidisciplinary education with a major milestone—its School of Pharmacy…